Clinical and experimental studies of Alzheimer’s disease indicate, among other aspects, amyloid deposition and modification of the tau protein, as well as damage to pyramidal neurons in the CA3 area of the hippocampus, associated with learning and memory deficits [1,2,3,4,5]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.